Volume 122, Issue 3, Pages 641-645 (March 2002) Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study Marcia Cruz–Correa, Linda M. Hylind, Katharine E. Romans, Susan V. Booker, Francis M. Giardiello Gastroenterology Volume 122, Issue 3, Pages 641-645 (March 2002) DOI: 10.1053/gast.2002.31890 Copyright © 2002 American Gastroenterological Association Terms and Conditions
Fig. 1 Relationship between polyp regression and dosage of sulindac (mg · kg−1 · day−1) at last follow-up. *Polyp regression on sulindac expressed as percent of baseline polyp number after 12 months of treatment with sulindac (numbers correspond to the identification numbers of each patient from Table 2). Gastroenterology 2002 122, 641-645DOI: (10.1053/gast.2002.31890) Copyright © 2002 American Gastroenterological Association Terms and Conditions